Connect with us

Leadership

Industry entrepreneurs predict 2022 CBD trends

As we get ready to welcome another year, we ask CBD industry insiders to predict what 2022 holds for the sector.

Published

on

As we get ready to welcome another year, we ask CBD industry insiders to predict what 2022 holds for the sector.

This year has been a difficult one for businesses but especially those in the CBD space. As well as navigating the novel food regulations, there have been supply issues, shipping problems, lockdowns and Covid-19 restrictions. Now that we have vaccines yet new strains, new regulations and also the publication of the Novel foods list coming in the new year, we ask:

What’s next for 2022?

We asked a few cannabis and CBD brands where they see the industry heading next year and what opportunities, or difficulties, to expect.

Fergus Kerrigan founder of Ethos CBD : European consolidation and the Irish market

Irish brand Ethos CBD was founded by Fergus Kerrigan and Amy O’ Flaherty in 2020. They offer a range of CBD oils, tea and they have recently moved into the topicals market with the creation of a new balm.

Fergus said: “When it comes to Europe, we believe there will be greater consolidation in the CBD industry with the number of brands reducing, but the overall quality of products going up. This will be spurred on by stricter regulatory conditions and by increased customer knowledge on what represents quality. Customers will demand functional products that help their individual wellbeing needs.”

When it comes to the Irish market, he explained that Ireland has been slower to adopt CBD but it’s getting there:

“Ireland has been a much slower adopter of CBD than the UK, however, we have noticed a tipping point in the customer perception of CBD. The conversation is much more open and educated and it’s getting wider coverage from the quality press. This is a positive sign for the growth and adoption of CBD products however there are key challenges, mainly poor contradictory regulation and lack of investment in hemp farming.”

Marc Burbidge, CEO of B3 labs: Terpenes in CBD and a boost for the drinks industry.

When it comes to industry trends for next year, Marc believes it will be the year where terpenes and blends become important, along with CBG.

“When I came into the industry, it was all about herbs, terpenes and different cannabinoids for me. When I spoke about this, people looked at me like I was a bit odd but this is exactly what’s happening now.

“Another key area will be the innovation in encapsulations, increased bioavailability and potentially more growth in the drinks. That’s where I see the industry wanting to go, but whether the regulatory framework will allow it to go there is another question.”

Danny Purton of Herbotany Health: on the public list.

Danny predicts that the public list will cause some uncertainty for brands which should last well into 2022.

“The big one for the industry is the public list. Whoever is on the public list, then their products will have a pathway to show they are safe as the efficacy will be what it says on the bottle. There will definitely be an industry acclimation for CBD brands where some will miss out, some will have to start the process from scratch or get help from other companies.

Danny also hopes to see more freedom with what brands can and cannot say about CBD.

“I’ve had a number of clients come to me who have had really bad times with Covid or have debilitating long Covid symptoms. They take CBD and say to us that it changed their life in terms of improvements. These are the stories we love and why we went into CBD but we can’t tell the public and that’s so frustrating.”

Predicts: Natalie from Empwr Botanics

Natalie Meredith, Founder of Empwr Botanics: CBD in skincare

Natalie predicts that more of the big brands will be adding CBD to their main ranges.

“One trend I’ve noticed is skincare. I see big companies starting to put CBD into their skincare range like Body Shop, Boots or Superdrug so it’s definitely catching on.

“Until the FSA decide to approve some applications for oils and other products, there are going to end up being a few stand out companies who have the money to advertise. Those who have the resources are going to be the stand out ones when it comes to anything consumable like oils or capsules.”

She also sees CBD playing a bigger part in wellness based on the American industry.

“I think CBD is going to go in a positive direction but it will be a struggle to find better ways to regulate it. It will become easier and a normal lifestyle thing rather than a trend everyone is jumping on. If America is any blueprint to go off then it will be a lifestyle thing where everyone says, ‘of course, I take CBD, don’t you?'”

Jeff Chen, Radicle Science: on the US outlook and growth in minor cannabinoids

Jeff predicts that there will be a call for more clarity around CBD in the US.

“One big development is the call for regulatory clarity in the US. CBD sits in a limbo where people are selling it but the FDA keeps saying you can’t sell this and it needs to be [classed as] a pharmaceutical drug. It has prevented major retailers from selling CBD and interfered with banking, credit card processing, even advertising. That’s really unfortunate. There needs to be more clarity.”

He added: “I know a congressional member has tried to pass bills, so who knows when this clarity is going to come or if the regulation is going to be stricter or less strict than it is now. The regulatory clarity is something I hope we see in 2022.

Jeff also highlighted the growth in minor cannabinoids.

“There is a growing amount of interest in the minor cannabinoids. People are starting to talk about CBG and CBC or even Delta-8 THC. People are finally thinking beyond THC or CBD to the world of the multiple cannabinoids that are available. Now thanks to demand, people are starting to breed different strains that produce cannabinoids.  Normally they are found in such small amounts in the plant that people are genetically engineering microbes that can effectively produce these minor cannabinoids.”

Predicts: A box of DNA CBD

David Molloy, founder of DNA CBD: CBD education and CBD isolate

David predicts that the industry will see more scientific evidence come to light, and also a growth in CBD isolate on the market.

“I think there will be an increasing number of health practitioners intrigued about the burgeoning evidence surrounding CBD and its constituents as a whole plant and as a safe and well-tolerated supplement. Education will be on the rise which will be great for the industry and the communities at large, and with that a move from CBD being a last resort to consider a practical first response.

“We have already seen a huge trend due to regulation towards a reductionist health approach with more CBD isolate on the market. It will be important for customers to appreciate that these are six to 10 times less potent, mix easier with medications and are harder to acquire the effective dose. I feel we should be ensuring choice that reflects the growing nutritional movement of gut diversity, whole foods and therefore whole plant CBD in line with this global trend especially considering its heightened safety profile and potency.”

Click to comment

Leave a Reply

Your email address will not be published.

Leadership

Canopy Growth appoints industry veteran Christelle Gedeon as chief legal officer

Gedeon’s cannabis and commercial expertise will further Canopy Growth’s strategy for North American cannabis leadership, the company said.

Published

on

canopy growth appoints Christelle Gedeon as chief legal officer

Christelle Gedeon is one of Canada’s Law Department Leaders of the Year and formally served as chief legal officer at the international cannabis firm Aphria.

Canopy Growth has appointed Christelle Gedeon as its new chief legal officer. Listed on the Legal 500 GC Powerlist in 2020 and the 2019 Canadian General Counsel Awards Tomorrow’s Leader, Gedeon is a commercial lawyer and strategist with more than a decade of legal and strategic experience.

Most recently she acted as chief legal officer and corporate secretary for The Metals Company (TMC). Prior to this, she served as the chief legal officer and corporate secretary at Aphria Inc, where she oversaw the reverse takeover of Tilray.

“Christelle is a proven leader in the legal and cannabis industries, and we are excited to have her join Canopy Growth as we continue to build the leading brand-driven cannabis company in North America,” said David Klein, CEO of Canopy Growth.

“As a company, we have set clear priorities including achieving profitability while advancing our competitive positioning through a premium focus in Canada, high-impact CPG brands and the continued growth of our US THC ecosystem. I am confident that Christelle’s commercial and legal acumen will be key to further bringing our strategy to fruition.”

In addition to her expertise in the cannabis industry, Gedeon brings experience with complex regulatory structures, intellectual property management, corporate governance, government relations and strategic acquisitions.

She has also had a direct role in the completion of more than 50 mergers, acquisitions and strategic investments including during her time as a partner at Fasken, a leading Canadian law firm, where she advised life sciences clients on commercial, regulatory and government affairs matters.

Gedeon received her Bachelor of Law from McGill University and is a member of both the Ontario and Quebec bars. She is also a registered trademark agent and holds a PhD in Clinical Pharmacology and Toxicology from the University of Toronto. Her appointment to the role of Chief Legal Officer at Canopy Growth is effective immediately.

Continue Reading

Leadership

‘The hemp revolution has already happened, now it needs reigniting’

Published

on

hemp farms Australia

Hemp fibre produces some of the strongest and most durable materials in the world and absorbs more carbon than pine trees. Hemp Farms Australia believes interest in the plant needs reigniting.

Cannabis Wealth sat down with Lauchlan Grout, co-founder of the Australian industrial hemp farming agribusiness, Hemp Farms Australia. The company was launched in 2013 by Grout and his childhood friend Harrison Lee to cultivate, process and sell the primary components of industrial hemp.

A dedicated seed supplier, Hemp Farms Australia was one of the first players in Australia’s hemp industry. The company specialises in variations of the plant that perform well in sub-tropical environments, a rare thing for a plant that originated in the icy tundras of Siberia.

Now a leader in hemp seed genetics, the company supplies seeds for growing grain for food and growing fibre for animal bedding, hempcrete and bioplastics. Grout talks about his passion for hemp and its potential to tackle the growing threat of climate change.

How did you get into the hemp sector?

After school, Harrison and I both went to work for his family in their abattoir here in Brisbane. They supply a couple of big grocery stores and supermarket chains with beef. We started on the kill floor and then went to the boning room. That was about five or six years of work experience in the abattoir as well as out on their farm. We learned there are so many facets to a supply chain.

At the time, hemp was being brought up a lot as this wonder crop; there were 70,000 uses for it apparently, but that just didn’t make sense because we hadn’t seen it anywhere. If there were so many uses for hemp, why wasn’t it being used?

So we dug deeper into that side of it and realised that all the different prohibition laws and the fact that hemp was so closely related to cannabis meant both of them, in Australia and many parts of the world, were illegal to grow even as for food or fibre.

But not many people realise that back in the day, the British and Russian naval fleets were all kitted out with hemp sales and hemp ropes because it was the most durable fibre in the world. All that knowledge and all that belief and all that industry were lost so we saw it as an opportunity to bring back something that could actually have a great impact on people and the environment.

Why is sustainability so important to you as a company?

The Earth is not heading in a nice direction in terms of the environment and climate. The climate extremes that we’ve seen in the last ten years here are comparable to what farmers have spoken about over the past 60 years. It seems like the events of those 60 years have repeated themselves in the past ten but double the scale and in a harsher fashion.

Farming is not easy. You have to budget for one in three crops to fail; it’s sometimes a business that can make you extremely depressed and that’s why so many farmers kill themselves; it’s terrible. They just have no water and if you have no water, you can’t do anything.

If I can do something that would not only help potentially reverse climate change or at least stop temperatures fluctuating so heavily by reducing the amount of carbon in our atmosphere, I want to do it.

Hemp is the highest carbon sequestering plant and one of the most sustainable protein-producing plants in the world. Hemp can reduce the amount of carbon in our atmosphere on a scale 40 times larger than a pine forest. Not only does it suck out the carbon, but it also locks it in the plant material so you can then build a car with that and produce fuel. Henry Ford built a car back in the 1940s out of hemp plastic that ran on hemp biofuel.  All this stuff has been around but it just needs to be reignited.

What are some of the biggest challenges you have faced on your journey running Hemp Farms Australia?

The first five years were challenging but also hopeful. Every mistake that we made hadn’t been made before because no one else had stepped that far yet. In other established industries and markets, you can read books or you can speak to people to find out what not to do, whereas in this sector there was none of that.

For example, nobody knew that you have to store industrial hemp at a certain temperature and in a certain humidity once you’ve harvested it, otherwise it will go mouldy within two or three days.

With our first crop, we harvested 40 tonnes of seed, we put it in an aerated silo which had heaps of fans running through it, but it was partially in the sun in a big metal container. We came back to check on it two days later and you could smell the mould from where we parked hundreds of metres away.

There were 40 tonnes of seed there worth every bit of $10 a kilo. That’s $400,000 worth of seed.

How have things changed since the early days of setting up Hemp Farms Australia and what have you learned?

We’ve got great advisors now and our key cornerstone investor is a very wise and smart agricultural businessman, so the last three years have been a lot different to the previous five.

I’ve learned that if you have something of value, then it’s worth risking a lot more than you think you would ever risk. I was questioning myself in the early days. I was doing it because I believed it will have a good impact on the world and the environment and the people living in it, but is it going to make me any money? Am I going to be able to build a family off of this? Those things were running in my head so much because things were ticking but they weren’t ticking the way we thought they would.

But I think the biggest thing I learned is If you believe something and you know in your gut that it will happen or it should happen then do not stop; the maths doesn’t need to line up. If money is the only thing that’s stopping you from keeping on the grind, then you shouldn’t be grinding it.

You run the business with a close school friend. How do you find running a business with one of your best mates?

Harrison and I have been very close friends – pretty much best friends – since year seven at school. We weren’t very fond of each other to begin with. He was very much into gaming. I was very much into sports. But he taught me the world of gaming and I taught him the world of sport and we became very close friends after that.

Never ever get into business with your best friend is what everyone told us. I will admit, we’ve been through some pretty bad times, to the point where we were not talking to each other, but you get over it, you harden up and you laugh about it.

We suddenly just said to each other ‘business is business and friendship is friendship’. We both have to pull our weight and we can’t be bickering at each other just because we know each other in and out.

Why are you proud to be part of the hemp and cannabis industry?

Not only can you heal people medicinally, but you can also house people through the fibres, you can clothe people through the fibres. There’s so much that hemp can do for people. Hemp revolutionised things back in the day, it’s now about reigniting it to a level where we can make a change.

Continue Reading

Leadership

Gerardo Gorostiza joins team at Linneo Health

Linneo Health has appointed Gorostiza as chief financial and strategy officer.

Published

on

Gerardo Gorostiza joins team at Linneo Health
Home » Leadership » Industry entrepreneurs predict 2022 CBD trends

Gorostiza will be bringing experience of corporate finance, strategic planning, business transformation and corporate development to the Linneo Health team.

Medical cannabis research and cultivation company Linneo Health has welcomed Gorostiza as Chief Financial and Strategy Officer.

The company has stated that Gorostiza possesses a track record of success leading the financial and strategy functions of a number of multinational businesses, both private and publicly listed.

Read more: Linneo Health explores trends in medical cannabis

Linneo Health CEO, Don Bellamy, commented: “We are delighted to welcome Gerardo to Linneo Health as chief financial and strategy officer. 

“He brings a wealth of experience and knowledge, and his strategic mindset and leadership skills will be invaluable to Linneo as we continue to build on our success and growth as the leading provider of medicinal cannabis, for the benefit of patients.”

Gorostiza’s previous roles include Uralita, Adveo and Grupo Costa Food, as well as having worked as a consultant with PricewaterhouseCoopers. 

Read more: GMP certification allows Linneo Health to continue cannabis research

Most recently, Gorostiza was CFO and subsequently CEO of Juan Luna, a leading Spanish food processing company, where he played an integral role in the professionalisation of the company and its subsequent sale to a top industrial player.

Gorostiza holds an Executive MBA from the IE Business School in Madrid, Spain, and qualified as an Industrial Engineer with the Universidad del País Vasco, Spain.

Gorostiza commented: “Linneo Health’s fully integrated platform, enabling the research, manufacture and supply of the highest quality medicinal cannabis, puts the company in a prime position to grow at scale as this market matures.

“I am looking forward to working with Don and the team to maintain Linneo’s leading position and continue its expansion.”

Gerardo Gorostiza joins team at Linneo Health

Continue Reading
Sign up for the Cannabis Wealth newsletter

Recent Posts

[class^="wpforms-"]
[class^="wpforms-"]